NuVasive, Inc. (NUVA)

1 member of Congress has disclosed 10 trades in NuVasive, Inc. (NUVA) via STOCK Act filings. The most recent disclosure was a sale by Lois Frankel on 14 February 2022. Aggregate disclosed activity totals roughly $48K in purchases and $32K in sales (midpoint estimates from bracketed disclosure amounts).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Price data is not available for NUVA
This ticker may have been delisted, renamed, or is not publicly quoted, so no live price, statistics or chart can be shown. The congressional trades disclosed for it are listed below.

Congressional Trading Activity for NUVA

5 transactions
Compliance: 50%
Lois Frankel14 Feb 202227 Feb 2022SaleStock$1,001 - $15,000N/A
Lois Frankel14 Feb 20226 Jun 2023SaleStock$1,001 - $15,000N/A
Lois Frankel14 Feb 201925 Feb 2019SaleStock$1,001 - $15,000N/A
Lois Frankel14 Feb 201910 Aug 2020SaleStock$1,001 - $15,000N/A
Lois Frankel15 Jun 201813 May 2019PurchaseStock$1,001 - $15,000N/A

See every trade

Sign in free to see the full trade history for this stock.

Stock Overview

Market Data

Market Cap

$2.08B

Volume

30.59M

Beta

1.07

P/E Ratio

75.00

Fundamentals

EPS

$0.53

Div. Yield

-

Open

$40.62

Day Range

$39.51 – $40.96

Company Information

Sector
Healthcare
Industry
Medical - Devices
Exchange
NASDAQ · USD
Country
US
CEO
J. Christopher Barry
IPO Date
2004-05-13

NuVasive, Inc. is a medical technology firm focused on creating, producing, and distributing comprehensive procedural solutions for spinal operations. The company offers a range of surgical access instruments, such as the Maxcess integrated split-bla...

Earnings

Recent Quarters

Q2 202431 Jul
EPS-
Q1 20248 May
EPS-
Q4 202320 Feb
EPS-
Q3 20238 Nov
EPS-
Q2 20232 Aug
EPS$0.56
Beat 0.0%
Q1 202310 May
EPS$0.47
Beat 14.6%
Q4 202222 Feb
EPS$0.43
Miss 15.7%
Q3 20229 Nov
EPS$0.54
Beat 1.9%
Q2 20223 Aug
EPS$0.47
Miss 14.6%
Q1 20224 May
EPS$0.54
Beat 42.1%
Q4 202123 Feb
EPS$0.40
Miss 14.9%
Q3 20219 Nov
EPS$0.32
Miss 40.7%
Q2 202128 Jul
EPS$0.60
Beat 39.5%
Q1 20215 May
EPS$0.37
Beat 12.1%
Q4 202025 Feb
EPS$0.59
Beat 7.3%
Q3 202029 Oct
EPS$0.54
Beat 100.0%
Q2 20204 Aug
EPS$0.40
Miss 18.4%
Q1 20206 May
EPS$0.48
Beat 37.1%
Q4 201920 Feb
EPS$0.73
Beat 14.1%
Q3 201930 Oct
EPS$0.59
Beat 9.3%
Q2 201930 Jul
EPS$0.63
Beat 12.5%
Q1 20191 May
EPS$0.53
Beat 29.3%
Q4 201820 Feb
EPS$0.69
Beat 9.5%
Q3 201830 Oct
EPS$0.56
Miss 11.1%
Q2 201831 Jul
EPS$0.58
Beat 0.0%
Q1 20181 May
EPS$0.39
Miss 13.3%
Q4 201726 Feb
EPS$0.56
Beat 0.0%
Q3 201724 Oct
EPS$0.52
Beat 8.3%
Q2 201727 Jul
EPS$0.46
Beat 4.5%
Q1 201725 Apr
EPS$0.38
Beat 2.7%
Q4 20169 Feb
EPS$0.53
Beat 6.0%
Q3 201625 Oct
EPS$0.40
Miss 2.4%
Q2 201626 Jul
EPS$0.40
Beat 11.1%
Q1 201626 Apr
EPS$0.32
Beat 18.5%
Q4 201511 Feb
EPS$0.35
Beat 16.7%
Q3 201527 Oct
EPS$0.35
Beat 29.6%
Q2 201528 Jul
EPS$0.31
Beat 29.2%
Q1 20154 May
EPS$0.30
Beat 42.9%
Q4 201424 Feb
EPS$0.39
Beat 8.3%
Q3 201430 Oct
EPS$0.19
Miss 24.0%
Q2 201429 Jul
EPS$0.28
Beat 12.0%
Q1 201429 Apr
EPS$0.29
Beat 38.1%
Q4 20133 Mar
EPS$0.37
Beat 19.4%
Q3 201329 Oct
EPS$0.39
Beat 62.5%
Q2 201330 Jul
EPS$0.21
Miss 12.5%
Q1 201330 Apr
EPS$0.26
Beat 30.0%
Q4 201226 Feb
EPS$0.34
Beat 70.0%
Q3 201224 Oct
EPS$0.23
Beat 9.5%
Q2 201225 Jul
EPS$0.27
Beat 17.4%
Q1 201230 Apr
EPS$0.20
Beat 11.1%
Q4 201122 Feb
EPS$0.27
Beat 22.7%
Q3 201127 Oct
EPS$0.26
Beat 13.0%
Q2 201125 Jul
EPS$0.30
Beat 3.5%
Q1 20114 May
EPS$0.24
Beat 26.3%
Q4 201023 Feb
EPS$0.46
Beat 9.5%
Q3 201028 Oct
EPS$0.46
Beat 9.5%
Q2 201027 Jul
EPS$0.42
Beat 44.8%
Q1 201020 Apr
EPS$0.21
Beat 5.0%
Q4 200925 Feb
EPS$0.11
Beat 22.2%
Q3 200920 Oct
EPS$0.11
Beat 120.0%
Q2 200923 Jul
EPS$0.11
Beat 696.0%
Q1 200922 Apr
EPS$-0.02
Beat 90.0%
Q4 200825 Feb
EPS$0.16
Beat 23.1%
Q3 200822 Oct
EPS$0.04
Beat 300.0%
Q2 200824 Jul
EPS$-0.01
Miss 72.0%
Q1 200822 Apr
EPS$-0.10
Beat 9.1%
Q4 200719 Feb
EPS$-0.03
Miss 30.8%
Q3 200724 Oct
EPS$-0.07
Beat 22.2%
Q2 200725 Jul
EPS$-0.10
Beat 23.1%
Q1 200725 Apr
EPS$-0.13
Beat 31.6%
Q4 200620 Feb
EPS$-0.08
Beat 27.3%
Q3 200625 Oct
EPS$-0.26
Beat 0.0%
Q2 200627 Jul
EPS$-0.21
Beat 12.5%
Q1 200627 Apr
EPS$-0.27
Beat 20.6%
Q4 200516 Feb
EPS$-0.14
Beat 6.7%
Q3 200527 Oct
EPS$-0.19
Miss 26.7%
Q2 200528 Jul
EPS$-0.17
Miss 54.5%
Q1 200526 Apr
EPS$-0.11
Beat 31.3%
Q4 200417 Feb
EPS$-0.12
Beat 20.0%
Q3 200426 Oct
EPS$-0.12
Beat 20.0%
Q2 200428 Jul
EPS$-0.34
Miss 47.8%
Q4 200331 Mar
EPS$-2.33
Q1 200330 Jun
EPS$-1.26
Q4 200231 Mar
EPS$-1.67

2 politicians traded within 30 days

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about NUVA

Which members of Congress have traded NUVA?
1 member of Congress has disclosed 10 trade in NuVasive, Inc. (NUVA) under the STOCK Act: Lois Frankel.
When was NUVA most recently disclosed by Congress?
The most recent NUVA disclosure was a sale by Lois Frankel on 14 February 2022.
What is the total disclosed congressional trading volume for NUVA?
Members of Congress have disclosed approximately $48K in NUVA purchases and $32K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in NUVA?
This NUVA page updates as soon as new STOCK Act disclosures are filed for NuVasive, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.